Literature DB >> 10334993

Bile acids: natural ligands for an orphan nuclear receptor.

D J Parks1, S G Blanchard, R K Bledsoe, G Chandra, T G Consler, S A Kliewer, J B Stimmel, T M Willson, A M Zavacki, D D Moore, J M Lehmann.   

Abstract

Bile acids regulate the transcription of genes that control cholesterol homeostasis through molecular mechanisms that are poorly understood. Physiological concentrations of free and conjugated chenodeoxycholic acid, lithocholic acid, and deoxycholic acid activated the farnesoid X receptor (FXR; NR1H4), an orphan nuclear receptor. As ligands, these bile acids and their conjugates modulated interaction of FXR with a peptide derived from steroid receptor coactivator 1. These results provide evidence for a nuclear bile acid signaling pathway that may regulate cholesterol homeostasis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10334993     DOI: 10.1126/science.284.5418.1365

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  604 in total

Review 1.  Hepatocellular transport proteins and their role in liver disease.

Authors:  C Stanca; D Jung; P J Meier; G A Kullak-Ublick
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

2.  New horizons in the regulation of bile acid and lipid homeostasis: critical role of the nuclear receptor FXR as an intracellular bile acid sensor.

Authors:  M Arrese; S J Karpen
Journal:  Gut       Date:  2001-10       Impact factor: 23.059

3.  Metformin-induced glucagon-like peptide-1 secretion contributes to the actions of metformin in type 2 diabetes.

Authors:  Emilie Bahne; Emily W L Sun; Richard L Young; Morten Hansen; David P Sonne; Jakob S Hansen; Ulrich Rohde; Alice P Liou; Margaret L Jackson; Dayan de Fontgalland; Philippa Rabbitt; Paul Hollington; Luigi Sposato; Steven Due; David A Wattchow; Jens F Rehfeld; Jens J Holst; Damien J Keating; Tina Vilsbøll; Filip K Knop
Journal:  JCI Insight       Date:  2018-12-06

4.  A novel heterozygous NR1H4 termination codon mutation in idiopathic infantile cholestasis.

Authors:  Xiu-Qi Chen; Lin-Lin Wang; Qing-Wen Shan; Qing Tang; Ya-Nan Deng; Shu-Jun Lian; Xiang Yun
Journal:  World J Pediatr       Date:  2011-06-01       Impact factor: 2.764

5.  Lowering bile acid pool size with a synthetic farnesoid X receptor (FXR) agonist induces obesity and diabetes through reduced energy expenditure.

Authors:  Mitsuhiro Watanabe; Yasushi Horai; Sander M Houten; Kohkichi Morimoto; Taichi Sugizaki; Eri Arita; Chikage Mataki; Hiroyuki Sato; Yusuke Tanigawara; Kristina Schoonjans; Hiroshi Itoh; Johan Auwerx
Journal:  J Biol Chem       Date:  2011-06-01       Impact factor: 5.157

6.  Bile acid signaling and bariatric surgery.

Authors:  Jingyan Tian; Silvia Huang; Siming Sun; Lili Ding; Eryun Zhang; Wendong Huang
Journal:  Liver Res       Date:  2017-12

7.  Lithocholic acid is an endogenous inhibitor of MDM4 and MDM2.

Authors:  Simon M Vogel; Matthias R Bauer; Andreas C Joerger; Rainer Wilcken; Tobias Brandt; Dmitry B Veprintsev; Trevor J Rutherford; Alan R Fersht; Frank M Boeckler
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-03       Impact factor: 11.205

8.  Identification of the Bile Acid Transporter Slco1a6 as a Candidate Gene That Broadly Affects Gene Expression in Mouse Pancreatic Islets.

Authors:  Jianan Tian; Mark P Keller; Angie T Oler; Mary E Rabaglia; Kathryn L Schueler; Donald S Stapleton; Aimee Teo Broman; Wen Zhao; Christina Kendziorski; Brian S Yandell; Bruno Hagenbuch; Karl W Broman; Alan D Attie
Journal:  Genetics       Date:  2015-09-18       Impact factor: 4.562

Review 9.  Bile acids: chemistry, physiology, and pathophysiology.

Authors:  Maria J Monte; Jose J G Marin; Alvaro Antelo; Jose Vazquez-Tato
Journal:  World J Gastroenterol       Date:  2009-02-21       Impact factor: 5.742

Review 10.  The Farnesoid X Receptor (FXR) as modulator of bile acid metabolism.

Authors:  Folkert Kuipers; Thierry Claudel; Ekkehard Sturm; Bart Staels
Journal:  Rev Endocr Metab Disord       Date:  2004-12       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.